Illumina's NovaSeq 6000 stands as the latest breakthrough in ultra-high throughput NGS sequencing instrumentation. This dual flow cell instrument is meticulously designed to function with four ...

software and analytics helped to create high-efficiency dual system imaging sequencers that could double the output without changing the cost of preparing a flow cell. Illumina has contributed to ...

The NovaSeq X Plus instrument is now available and ready for submissions! The 2-channel chemistry, patterned flow-cells are best for large scale genomic, epigenomic, and transcriptome sequencing. With ...

Last month, Illumina Inc (NASDAQ:ILMN) had to let go of Grail Inc. (NASDAQ:GRAL). Still, the DNA sequencing company has ...

This device combines photo-electrochemical solar cells with aqueous organic redox-flow battery technology and has solar-to-output efficiency of 20.1%. This content is protected by copyright and ...

【第2集】BBC.The.Cell- 细胞 - 科普类型纪录片(1)（中） 译 BBC.The.Cell- 细胞 - 科普类型纪录片 - BBC.The.Cell- 细胞 - 科普类型纪录片(1)（中） ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

Repurchase of Common & Preferred Stk. Repurchase of Common & Preferred Stk.

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of ...

among people with RET fusion-positive non-small cell lung cancer (NSCLC). The latter is a new addition compared to the EU version of the test. Those green lights, according to Illumina ...

BRUSSELS (Reuters) -U.S. gene sequencing company Illumina on Tuesday won its court fight against the European Union's investigation of its $7.1 billion purchase of cancer diagnostic test maker Grail, ...